[HTML][HTML] Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM …
H Cederberg, A Stančáková, N Yaluri, S Modi… - Diabetologia, 2015 - Springer
H Cederberg, A Stančáková, N Yaluri, S Modi, J Kuusisto, M Laakso
Diabetologia, 2015•SpringerMethods A total of 8,749 non-diabetic participants, aged 45–73 years, were followed up for
5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA 1c≥
6.5%(48 mmol/mol) or glucose-lowering medication started during the follow-up. Insulin
sensitivity and secretion were evaluated with OGTT-derived indices. Results Participants on
statin treatment (N= 2,142) had a 46% increased risk of type 2 diabetes (adjusted HR 1.46
[95% CI 1.22, 1.74]). The risk was dose dependent for simvastatin and atorvastatin. Statin …
5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA 1c≥
6.5%(48 mmol/mol) or glucose-lowering medication started during the follow-up. Insulin
sensitivity and secretion were evaluated with OGTT-derived indices. Results Participants on
statin treatment (N= 2,142) had a 46% increased risk of type 2 diabetes (adjusted HR 1.46
[95% CI 1.22, 1.74]). The risk was dose dependent for simvastatin and atorvastatin. Statin …
Methods
A total of 8,749 non-diabetic participants, aged 45–73 years, were followed up for 5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA 1c≥ 6.5%(48 mmol/mol) or glucose-lowering medication started during the follow-up. Insulin sensitivity and secretion were evaluated with OGTT-derived indices.
Results
Participants on statin treatment (N= 2,142) had a 46% increased risk of type 2 diabetes (adjusted HR 1.46 [95% CI 1.22, 1.74]). The risk was dose dependent for simvastatin and atorvastatin. Statin treatment significantly increased 2 h glucose (2hPG) and glucose AUC of an OGTT at follow-up, with a nominally significant increase in fasting plasma glucose (FPG). Insulin sensitivity was decreased by 24% and insulin secretion by 12% in individuals on statin treatment (at FPG and 2hPG< 5.0 mmol/l) compared with individuals without statin treatment (p< 0.01). Decreases in insulin sensitivity and insulin secretion were dose dependent for simvastatin and atorvastatin.
Springer
